Intranasal 5-MeO-DMT effects are drawing increasing attention from researchers interested in fast-acting psychedelic compounds and their potential relevance to mental health and consciousness science
A new study published in Scientific Reports provides one of the clearest timelines to date of how this substance affects perception, emotion, and awareness when delivered through the nasal route.
5-methoxy-N,N-dimethyltryptamine, commonly known as 5-MeO-DMT, is a naturally occurring psychedelic found in certain plants and in the venom of the Sonoran Desert toad. It can also be synthesized in laboratory settings. Unlike classic psychedelics such as psilocybin or LSD, 5-MeO-DMT is known for producing very intense experiences that unfold and resolve rapidly.
Understanding The Study Design
The research team, led by Anna O. Ermakova, analyzed experiences from 40 healthy adults between the ages of 25 and 55 who had never used psychedelics before. These participants were part of a larger clinical trial that included 50 volunteers. In this substudy, 32 participants received a single intranasal dose of 5-MeO-DMT ranging from 1 to 12 milligrams, while 8 participants received a placebo.
The substance was administered as a dry powder through intranasal application. After dosing, participants reported their subjective intensity of effects for up to 90 minutes. Shortly after the session, they completed in-depth guided interviews describing their experiences. Researchers then applied natural language processing and machine learning tools to analyze recurring themes across the interview transcripts.
Intranasal 5-MeO-DMT Effects Peak Rapidly
One of the most striking findings was the speed of onset. Participants reported noticeable effects within zero to two minutes after intranasal administration. The peak of intranasal 5-MeO-DMT effects occurred between eight and fifteen minutes, making it one of the fastest-acting psychedelics studied in controlled settings.
After the peak, effects gradually diminished over the next 15 to 40 minutes. For most participants, the primary consciousness-altering effects ended within 45 to 60 minutes, although subtle effects sometimes lingered up to 90 minutes, especially at higher doses. Higher doses were associated with slightly longer peak periods and slower dissipation.
Emotional And Bodily Experiences Over Visual Effects
Unlike substances such as DMT or psilocybin, intranasal 5-MeO-DMT effects were not strongly visual. Participants rarely reported vivid imagery. Instead, the experience was described as emotionally intense, immersive, and often centered on bodily sensations and changes in self-awareness.
Common themes included altered emotional states, changes in cognition and metacognition, heightened arousal, and shifts in the perceived relationship between the self, others, and the surrounding environment. Many participants described a sense of ego dissolution or loss of personal boundaries, even in the absence of strong visual phenomena.
Implications For Mental Health Research
The authors note that the unique profile of intranasal 5-MeO-DMT effects may have implications for future therapeutic research. The combination of rapid onset, short duration, strong emotional content, and limited visuals could make the compound particularly interesting for controlled clinical environments. Participants sometimes reported emotional breakthroughs or personal insights, experiences that are often considered relevant in psychedelic-assisted therapy models.
However, the researchers emphasized caution. The sample size was relatively small, and the study was not designed to evaluate therapeutic outcomes or long-term effects. More research is needed to understand safety, dosing, and potential clinical applications.
As interest in innovative psychedelic modalities grows, studies like this help clarify how different compounds uniquely interact with human consciousness. Intranasal 5-MeO-DMT effects appear to stand apart from other psychedelics, offering a brief but powerful window into altered states that researchers are only beginning to explore.
Citations
- Ermakova AO, Dunbar F, Seynaeve M, Millière R. Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults. Scientific Reports. 2025;15:38874. https://www.nature.com/articles/s41598-025-22620-z
- Davis AK, Barsuglia JP, Lancelotta R, Grant RM, Renn E. The epidemiology of 5-MeO-DMT use and its subjective effects. Journal of Psychopharmacology. 2018. https://journals.sagepub.com/doi/10.1177/0269881118769063